{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:35:17Z","timestamp":1790771717880,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2022CFB448"],"award-info":[{"award-number":["2022CFB448"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2022CFB911"],"award-info":[{"award-number":["2022CFB911"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203829"],"award-info":[{"award-number":["82203829"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273451"],"award-info":[{"award-number":["82273451"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computer Methods and Programs in Biomedicine"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.cmpb.2024.108193","type":"journal-article","created":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T22:53:02Z","timestamp":1713999182000},"page":"108193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["A new high-throughput screening methodology for the discovery of cancer-testis antigen using multi-omics data"],"prefix":"10.1016","volume":"250","author":[{"given":"Dandan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zidi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiwei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8527-5278","authenticated-orcid":false,"given":"Shanshan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.cmpb.2024.108193_bib0001","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41588-023-01349-3","article-title":"Pan-cancer analysis identifies tumor-specific antigens derived from transposable elements","volume":"55","author":"Shah","year":"2023","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.cmpb.2024.108193_bib0002","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/15384047.2020.1833156","article-title":"Targeted drug delivery using an aptamer against shared tumor-specific peptide antigen of MAGE-A3","volume":"22","author":"Wang","year":"2021","journal-title":"Cancer Biol. Ther."},{"issue":"2","key":"10.1016\/j.cmpb.2024.108193_bib0003","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/biolre\/ioab074","article-title":"The PRAME family of cancer testis antigens is essential for germline development and gametogenesis","volume":"105","author":"Kern","year":"2021","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.cmpb.2024.108193_bib0004","first-page":"121","article-title":"Immunological and functional aspects of MAGEA3 cancer\/testis antigen","volume":"125","author":"Das","year":"2021","journal-title":"Adv. Protein Chem. Str."},{"issue":"1","key":"10.1016\/j.cmpb.2024.108193_bib0005","article-title":"The cancer\/testis genes: review, standardization, and commentary","volume":"4","author":"Scanlan","year":"2004","journal-title":"Cancer Immun."},{"issue":"4","key":"10.1016\/j.cmpb.2024.108193_bib0006","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1134\/S0026893320040093","article-title":"Regulation of gene expression of cancer\/testis antigens in colorectal cancer patients","volume":"54","author":"Kutilin","year":"2020","journal-title":"Mol. Biol."},{"issue":"1","key":"10.1016\/j.cmpb.2024.108193_bib0007","doi-asserted-by":"crossref","DOI":"10.1186\/s13578-023-01060-0","article-title":"Serine protease PRSS56, a novel cancer-testis antigen activated by DNA hypomethylation, promotes colorectal and gastric cancer progression via PI3K\/AKT axis","volume":"13","author":"Li","year":"2023","journal-title":"Cell Biosci."},{"issue":"1","key":"10.1016\/j.cmpb.2024.108193_bib0008","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.bbrc.2013.10.028","article-title":"A testis-specific serine protease, Prss41\/Tessp-1, is necessary for the progression of meiosis during murine in vitro spermatogenesis","volume":"441","author":"Yoneda","year":"2013","journal-title":"Biochem. Bioph. Res. Co."},{"issue":"5","key":"10.1016\/j.cmpb.2024.108193_bib0009","doi-asserted-by":"crossref","DOI":"10.1095\/biolreprod.112.106328","article-title":"Three testis-specific paralogous serine proteases play different roles in murine spermatogenesis and are involved in germ cell survival during meiosis","volume":"88","author":"Yoneda","year":"2013","journal-title":"Biol. Reprod."},{"issue":"1","key":"10.1016\/j.cmpb.2024.108193_bib0010","first-page":"84","article-title":"The testis-specific serine proteases PRSS44, PRSS46, and PRSS54 are dispensable for male mouse fertilitydagger","volume":"102","author":"Holcomb","year":"2020","journal-title":"Biol. Reprod."},{"issue":"1","key":"10.1016\/j.cmpb.2024.108193_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/mrd.20184","article-title":"TESSP-1: a novel serine protease gene expressed in the spermatogonia and spermatocytes of adult mouse testes","volume":"70","author":"Takano","year":"2005","journal-title":"Mol. Reprod. Dev."},{"key":"10.1016\/j.cmpb.2024.108193_bib0012","doi-asserted-by":"crossref","unstructured":"Li D., Xia L., Huang P., Wang Z., Guo Q., Huang C., et al. Cancer-associated fibroblast-secreted IGFBP7 promotes gastric cancer by enhancing tumor associated macrophage infiltration via FGF2\/FGFR1\/PI3K\/AKT axis. 2023;9(1):1\u201312.","DOI":"10.1038\/s41420-023-01336-x"},{"key":"10.1016\/j.cmpb.2024.108193_bib0013","doi-asserted-by":"crossref","DOI":"10.1038\/s41388-021-01948-6","article-title":"The ELF3-regulated lncRNA UBE2CP3 is over-stabilized by RNA-RNA interactions and drives gastric cancer metastasis via miR-138-5p\/ITGA2 axis","author":"Li","year":"2021","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.cmpb.2024.108193_bib0014","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1186\/s13046-022-02541-9","article-title":"LncRNA ELF3-AS1 inhibits gastric cancer by forming a negative feedback loop with SNAI2 and regulates ELF3 mRNA stability via interacting with ILF2\/ILF3 complex","volume":"41","author":"Li","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.cmpb.2024.108193_bib0015","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3389\/fonc.2019.00220","article-title":"IRF6 Is directly regulated by ZEB1 and ELF3, and predicts a favorable prognosis in gastric cancer","volume":"9","author":"Li","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cmpb.2024.108193_bib0016","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.955841","article-title":"Serine protease PRSS23 drives gastric cancer by enhancing tumor associated macrophage infiltration via FGF2","volume":"13","author":"Qin","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.cmpb.2024.108193_bib0017","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41420-023-01336-x","article-title":"Cancer-associated fibroblast-secreted IGFBP7 promotes gastric cancer by enhancing tumor associated macrophage infiltration via FGF2\/FGFR1\/PI3K\/AKT axis","volume":"9","author":"Li","year":"2023","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.cmpb.2024.108193_bib0018","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.omtn.2019.11.003","article-title":"LncRNA MAGI2-AS3 is regulated by BRD4 and promotes gastric cancer progression via maintaining ZEB1 overexpression by sponging miR-141\/200a","volume":"19","author":"Li","year":"2020","journal-title":"Mol. Ther. Nucl. Acids"},{"issue":"1","key":"10.1016\/j.cmpb.2024.108193_bib0019","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41419-022-04540-2","article-title":"The EMT-induced lncRNA NR2F1-AS1 positively modulates NR2F1 expression and drives gastric cancer via miR-29a-3p\/VAMP7 axis","volume":"13","author":"Li","year":"2022","journal-title":"Cell Death. Dis."},{"key":"10.1016\/j.cmpb.2024.108193_bib0020","doi-asserted-by":"crossref","first-page":"e13423","DOI":"10.1111\/cpr.13423","article-title":"Heterogeneity and plasticity of epithelial-mesenchymal transition (EMT) in cancer metastasis: focusing on partial EMT and regulatory mechanisms","author":"Li","year":"2023","journal-title":"Cell Prolif."},{"issue":"7","key":"10.1016\/j.cmpb.2024.108193_bib0021","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1002\/2211-5463.13125","article-title":"miRNA-194 predicts favorable prognosis in gastric cancer and inhibits gastric cancer cell growth by targeting CCND1","volume":"11","author":"Wang","year":"2021","journal-title":"FEBS. Open. Bio"},{"key":"10.1016\/j.cmpb.2024.108193_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1025594","article-title":"Genome-wide association studies identify miRNA-194 as a prognostic biomarker for gastrointestinal cancer by targeting ATP6V1F, PPP1R14B, BTF3L4 and SLC7A5","volume":"12","author":"Huang","year":"2022","journal-title":"Front. Oncol."},{"issue":"35","key":"10.1016\/j.cmpb.2024.108193_bib0023","doi-asserted-by":"crossref","first-page":"5403","DOI":"10.1038\/s41388-021-01948-6","article-title":"The ELF3-regulated lncRNA UBE2CP3 is over-stabilized by RNA-RNA interactions and drives gastric cancer metastasis via miR-138-5p\/ITGA2 axis","volume":"40","author":"Li","year":"2021","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.cmpb.2024.108193_bib0024","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ccell.2018.12.003","article-title":"Proteogenomic characterization of human early-onset gastric cancer","volume":"35","author":"Mun","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cmpb.2024.108193_bib0025","doi-asserted-by":"crossref","first-page":"12983","DOI":"10.1038\/ncomms12983","article-title":"Epigenomic profiling of primary gastric adenocarcinoma reveals super-enhancer heterogeneity","volume":"7","author":"Ooi","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cmpb.2024.108193_bib0026","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.canlet.2017.03.029","article-title":"Oncogenic roles of DNA hypomethylation through the activation of cancer-germline genes","volume":"396","author":"Van Tongelen","year":"2017","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.cmpb.2024.108193_bib0027","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/bjc.2017.168","article-title":"Molecular profiling of signet ring cell colorectal cancer provides a strong rationale for genomic targeted and immune checkpoint inhibitor therapies","volume":"117","author":"Alvi","year":"2017","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.cmpb.2024.108193_bib0028","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/cgt.2014.3","article-title":"Finding suitable targets is the major obstacle to cancer gene therapy","volume":"21","author":"Rosenberg","year":"2014","journal-title":"Cancer Gene Ther."},{"issue":"2","key":"10.1016\/j.cmpb.2024.108193_bib0029","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/CJI.0b013e3182829903","article-title":"Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy","volume":"36","author":"Morgan","year":"2013","journal-title":"J. ImmunOther"},{"issue":"7","key":"10.1016\/j.cmpb.2024.108193_bib0030","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1200\/JCO.2010.32.2537","article-title":"Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1","volume":"29","author":"Robbins","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cmpb.2024.108193_bib0031","first-page":"8","article-title":"The journey from autologous typing to SEREX, NY-ESO-1, and cancer\/testis antigens","volume":"12","author":"Chen","year":"2012","journal-title":"Cancer Immun."},{"issue":"9","key":"10.1016\/j.cmpb.2024.108193_bib0032","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1093\/bioinformatics\/btac116","article-title":"TSAFinder: exhaustive tumor-specific antigen detection with RNAseq","volume":"38","author":"Sharpnack","year":"2022","journal-title":"Bioinformatics."},{"key":"10.1016\/j.cmpb.2024.108193_bib0033","doi-asserted-by":"crossref","DOI":"10.1186\/s40425-019-0629-6","article-title":"Efficient identification of neoantigen-specific T-cell responses in advanced human ovarian cancer","volume":"7","author":"Liu","year":"2019","journal-title":"J. ImmunOther. Cancer"},{"issue":"5","key":"10.1016\/j.cmpb.2024.108193_bib0034","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14051243","article-title":"Valid-NEO: a multi-omics platform for neoantigen detection and quantification from limited clinical samples","volume":"14","author":"Terai","year":"2022","journal-title":"Cancers. (Basel)"},{"key":"10.1016\/j.cmpb.2024.108193_bib0035","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-03730-x","article-title":"Multi-omics analysis reveals neoantigen-independent immune cell infiltration in copy-number driven cancers","volume":"9","author":"McGrail","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cmpb.2024.108193_bib0036","first-page":"11","article-title":"Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma","author":"Loffler","year":"2019","journal-title":"Genome Med."},{"issue":"6","key":"10.1016\/j.cmpb.2024.108193_bib0037","article-title":"Biology of cancer-testis antigens and their therapeutic implications in cancer","volume":"12","author":"Nin","year":"2023","journal-title":"Cells Basel"},{"issue":"4","key":"10.1016\/j.cmpb.2024.108193_bib0038","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s00262-022-03307-0","article-title":"Peptide vaccine from cancer-testis antigen ODF2 can potentiate the cytotoxic T lymphocyte infiltration through IL-15 in non-MSI-H colorectal cancer","volume":"72","author":"Shi","year":"2023","journal-title":"Cancer Immunol. Immunther."},{"key":"10.1016\/j.cmpb.2024.108193_bib0039","doi-asserted-by":"crossref","DOI":"10.1038\/s41388-023-02690-x","article-title":"The cancer testis antigen TDRD1 regulates prostate cancer proliferation by associating with the snRNP biogenesis machinery","author":"Kim","year":"2023","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.cmpb.2024.108193_bib0040","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41420-022-00946-1","article-title":"The cancer\/testis antigen HORMAD1 mediates epithelial-mesenchymal transition to promote tumor growth and metastasis by activating the Wnt\/beta-catenin signaling pathway in lung cancer","volume":"8","author":"Liu","year":"2022","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.cmpb.2024.108193_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.154168","article-title":"The cancer-testis antigen FBXO39 predicts poor prognosis and is associated with stemness and aggressiveness in glioma","volume":"239","author":"Wu","year":"2022","journal-title":"Pathol. Res. Pract."}],"container-title":["Computer Methods and Programs in Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169260724001895?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169260724001895?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T15:39:18Z","timestamp":1715441958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169260724001895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":41,"alternative-id":["S0169260724001895"],"URL":"https:\/\/doi.org\/10.1016\/j.cmpb.2024.108193","relation":{},"ISSN":["0169-2607"],"issn-type":[{"value":"0169-2607","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A new high-throughput screening methodology for the discovery of cancer-testis antigen using multi-omics data","name":"articletitle","label":"Article Title"},{"value":"Computer Methods and Programs in Biomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmpb.2024.108193","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108193"}}